Tempus Compass

Tempus Compass

Tempus Compass brings end-to-end solutions across phase I-IV of therapeutic development. From discovery research, trial design, and patient enrollment to regulatory approval and post approvals, Compass is a full-service partner that can tailor solutions to any step of your oncology drug development cycle.

Visit Website

Locations

  • APAC
  • Australia
  • Europe
  • North America

Therapeutic Areas

  • Oncology

Tempus Compass is a specialized, full-service CRO founded from within an oncology biotech to provide a better solution. We understand the gap between what you need and what you get from a traditional CRO and we’re here to improve the status quo. Compass was built specifically to address the common problems that biotechs encounter with CROs. The combination of our corporate infrastructure, focus, and passion enables us to deliver higher-caliber, more engaged teams and allocate them appropriately to each project. This means that our Sponsors and research sites receive, and retain, A-team support and the attention they deserve from IND to market approval. We help innovators run smart development programs to reach critical milestones quickly and cost-effectively. We understand your challenges because we’ve lived them and our services are designed to ensure you get exactly what you need with the flexibility required for complex & adaptive trial designs, globally, from phase I to phase III.

Accreditations

Partners are trained on the functionality of the electronic data capture (EDC) and clinical data management (CDM) system, process optimization exercises and scope of Medidata Rave services. This Accreditation teaches the staff to perform end user training, user and site administration, study build, reporting, outputs and amendment manager.